Schedule 13G ownership disclosure

Palisade Bio, Inc.

Common Stock, par value $0.01 per share · CUSIP: 696389402

Event date: 2025-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Squadron Master Fund LP

    Shares: 4,500,000.00 · Class: 3.0%

  • Squadron Capital Management LLC

    Shares: 4,500,000.00 · Class: 3.0%

  • Matthew Sesterhenn

    Shares: 4,500,000.00 · Class: 3.0%

  • William Blank

    Shares: 4,500,000.00 · Class: 3.0%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0002050709-26-000006
Form type
SCHEDULE 13G/A
Filer
PALISADE BIO, INC.
CIK
CIK 1357459
Filed
Feb 17, 2026
Reporting period
Dec 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub